Low Excision and High Suspension Hemorrhoidectomy Versus Conventional Milligan-Morgan Hemorrhoidectomy for Grade III-IV Mixed Hemorrhoids

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorThe Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine

About this trial

Low Excision and High Suspension Hemorrhoidectomy versus Conventional Milligan-Morgan Hemorrhoidectomy for Mixed Hemorrhoids

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosed with Goligher grade III-IV mixed hemorrhoids via anorectal examination;

Failed conservative treatment for at least 3 months;

Voluntarily participated in the study and agreed to complete the 12-month follow-up.

Disqualifiers

History of previous anorectal surgery;

Severe coagulation dysfunction, cardiopulmonary insufficiency, hepatic/renal failure, or mental disorders;

Pregnancy or lactation;

Inability to cooperate with postoperative follow-up and evaluation.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Low Excision and High Suspension Hemorrhoidectomy

    Procedure/Surgery

    Low Excision and High Suspension Hemorrhoidectomy

  • Conventional Milligan-Morgan Hemorrhoidectomy

    Procedure/Surgery

    Conventional Milligan-Morgan Hemorrhoidectomy

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Study GroupExperimental treatment 1 intervention
Group B: control GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Clinical effective rate at 12 weeks postoperatively

Cured (complete resolution of symptoms and hemorrhoid prolapse) + improved (obvious relief of clinical symptoms) / total number of patients; an effective rate ≥90% was defined as clinically effective.

Time frame
12 weeks postoperatively
2

Hemorrhoid recurrence rate at 12 months postoperatively

Recurrence was defined as the reappearance of hemorrhoid prolapse or rectal bleeding requiring clinical reintervention during the follow-up period.

Time frame
12 months postoperatively

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: